Characteristics of Patients With Necrotizing Soft Tissue Infections
August 3, 2023 updated by: Per Gundtoft, Aarhus University Hospital
Demographic Characteristics, Symptoms, Treatment and Mortality of Patients With Necrotizing Soft Tissue Infections
To study the demographic characteristic of patients with necrotizing soft tissue infections.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
At Aarhus University Hospital, Denmark, all patients with necrotizing soft tissue infections will be registered in a database in order to be able to describe their symptoms, demographic variables and thier treatment (surgery, time to surgery, antibiotics, intensive care unit, laboratory data etc).
Study Type
Observational
Enrollment (Estimated)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: per gundtoft
- Phone Number: 26195112
- Email: pergun@rm.dk
Study Locations
-
-
-
Aarhus N, Denmark, 8200
- Recruiting
- Aarhus University Hospital
-
Contact:
- per gundtoft
- Phone Number: 26195112
- Email: pergun@rm.dk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
All patients admitted to Aarhus University Hospital with necrotizing soft tissue infections, either diagnosed prior to arriving to the hospital or diagnosed in the hospital.
Description
Inclusion Criteria:
- Patients diagnosed with necrotizing soft tissue infections and treated at Aarhus Universital Hospital
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of patients that dies within 1 year following admission date
Time Frame: 12 months following admission date
|
The risk of death within 1 year
|
12 months following admission date
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: per gundtoft, Aarhus University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2020
Primary Completion (Estimated)
January 1, 2025
Study Completion (Estimated)
June 1, 2025
Study Registration Dates
First Submitted
December 23, 2020
First Submitted That Met QC Criteria
March 12, 2021
First Posted (Actual)
March 17, 2021
Study Record Updates
Last Update Posted (Actual)
August 7, 2023
Last Update Submitted That Met QC Criteria
August 3, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ICD_20201212
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
We do not plan to share this with other researchers.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.